{"id":"https://openalex.org/W7223330581","doi":"https://doi.org/10.64898/2026.10.22.760891","title":"Whole-genome sequencing reveals tumor T-cell infiltration associated with immunotherapy outcomes","display_name":"Whole-genome sequencing reveals tumor T-cell infiltration associated with immunotherapy outcomes","publication_year":2026,"publication_date":"2026-10-23","ids":{"openalex":"https://openalex.org/W7223330581","doi":"https://doi.org/10.64898/2026.10.22.760891"},"language":"en","primary_location":{"id":"doi:10.64898/2026.10.22.760891","doi":"https://doi.org/10.64898/2026.10.22.760891","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.10.22.760891","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2026/10/23/2026.10.22.760891.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"},"volume":null,"type":"preprint","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.biorxiv.org/content/biorxiv/early/2026/10/23/2026.10.22.760891.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081406103","display_name":"Joseph L. Usset","orcid":"https://orcid.org/0000-0002-5820-9881","observed_orcids":["https://orcid.org/0000-0002-5820-9881"]},"institutions":[{"id":"https://openalex.org/I4210153313","display_name":"Hartwig Medical Foundation","ror":"https://ror.org/0428k0n93","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210153313"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES","NL"],"is_corresponding":false,"raw_author_name":"Joseph Usset","raw_affiliation_strings":["Hartwig Medical Foundation, Science Park 408, 1098 XH, Amsterdam, The Netherlands","Systems Oncology Program, Vall d\u2019Hebron Institute of Oncology (VHIO), Vall d\u2019Hebron Barcelona Hospital Campus, 08035, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hartwig Medical Foundation, Science Park 408, 1098 XH, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I4210153313"]},{"raw_affiliation_string":"Systems Oncology Program, Vall d\u2019Hebron Institute of Oncology (VHIO), Vall d\u2019Hebron Barcelona Hospital Campus, 08035, Barcelona, Spain","institution_ids":["https://openalex.org/I4387155398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159370038","display_name":"Hong Wing Lee","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hong Wing Lee","raw_affiliation_strings":["Hartwig Medical Foundation Australia, Miller Street, North Sydney, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hartwig Medical Foundation Australia, Miller Street, North Sydney, Australia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5134616487","display_name":"Reece Jones","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Reece Jones","raw_affiliation_strings":["Hartwig Medical Foundation Australia, Miller Street, North Sydney, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hartwig Medical Foundation Australia, Miller Street, North Sydney, Australia","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072525850","display_name":"Joep de Ligt","orcid":"https://orcid.org/0000-0002-0348-419X","observed_orcids":["https://orcid.org/0000-0002-0348-419X"]},"institutions":[{"id":"https://openalex.org/I4210153313","display_name":"Hartwig Medical Foundation","ror":"https://ror.org/0428k0n93","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210153313"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Joep De Ligt","raw_affiliation_strings":["Hartwig Medical Foundation, Science Park 408, 1098 XH, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hartwig Medical Foundation, Science Park 408, 1098 XH, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I4210153313"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159323246","display_name":"Edwin L Cuppen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153313","display_name":"Hartwig Medical Foundation","ror":"https://ror.org/0428k0n93","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210153313"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Edwin Cuppen","raw_affiliation_strings":["Hartwig Medical Foundation, Science Park 408, 1098 XH, Amsterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hartwig Medical Foundation, Science Park 408, 1098 XH, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I4210153313"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084480894","display_name":"Peter Priestley","orcid":"https://orcid.org/0000-0002-4939-7104","observed_orcids":["https://orcid.org/0000-0002-4939-7104"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter Priestley","raw_affiliation_strings":["Hartwig Medical Foundation Australia, Miller Street, North Sydney, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hartwig Medical Foundation Australia, Miller Street, North Sydney, Australia","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085923029","display_name":"Francisco Mart\u00ednez-Jim\u00e9nez","orcid":"https://orcid.org/0000-0001-7804-1134","observed_orcids":["https://orcid.org/0000-0001-7804-1134"]},"institutions":[{"id":"https://openalex.org/I4210153313","display_name":"Hartwig Medical Foundation","ror":"https://ror.org/0428k0n93","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210153313"]},{"id":"https://openalex.org/I4387155398","display_name":"Vall d'Hebron Institute of Oncology","ror":"https://ror.org/054xx3904","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4387153040","https://openalex.org/I4387155398"]}],"countries":["ES","NL"],"is_corresponding":true,"raw_author_name":"Francisco Mart\u00ednez-Jim\u00e9nez","raw_affiliation_strings":["Hartwig Medical Foundation, Science Park 408, 1098 XH, Amsterdam, The Netherlands","Systems Oncology Program, Vall d\u2019Hebron Institute of Oncology (VHIO), Vall d\u2019Hebron Barcelona Hospital Campus, 08035, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hartwig Medical Foundation, Science Park 408, 1098 XH, Amsterdam, The Netherlands","institution_ids":["https://openalex.org/I4210153313"]},{"raw_affiliation_string":"Systems Oncology Program, Vall d\u2019Hebron Institute of Oncology (VHIO), Vall d\u2019Hebron Barcelona Hospital Campus, 08035, Barcelona, Spain","institution_ids":["https://openalex.org/I4387155398"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5085923029"],"corresponding_institution_ids":["https://openalex.org/I4210153313","https://openalex.org/I4387155398"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.8679999709129333},{"id":"https://openalex.org/keywords/immunotherapy-response-prediction","display_name":"immunotherapy response prediction","score":0.8799999952316284},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.9670000076293945},{"id":"https://openalex.org/keywords/tumor-mutational-burden","display_name":"tumor mutational burden","score":0.7459999918937683},{"id":"https://openalex.org/keywords/metastatic-cancer","display_name":"metastatic cancer","score":0.6119999885559082},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.5220000147819519},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7609999775886536},{"id":"https://openalex.org/keywords/precision-oncology","display_name":"precision oncology","score":0.8109999895095825},{"id":"https://openalex.org/keywords/patient-stratification","display_name":"patient stratification","score":0.6769999861717224}],"concepts":[{"id":"https://openalex.org/C160798450","wikidata":"https://www.wikidata.org/wiki/Q4230870","display_name":"Concordance","level":2,"score":0.7660999894142151},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6899999976158142},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5885999798774719},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5884000062942505},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.583899974822998},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5364000201225281},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5346999764442444},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5320000052452087},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.42649999260902405},{"id":"https://openalex.org/C153400128","wikidata":"https://www.wikidata.org/wiki/Q3150731","display_name":"Infiltration (HVAC)","level":2,"score":0.41589999198913574},{"id":"https://openalex.org/C18431079","wikidata":"https://www.wikidata.org/wiki/Q1502169","display_name":"Gene expression profiling","level":4,"score":0.3749000132083893},{"id":"https://openalex.org/C2778326572","wikidata":"https://www.wikidata.org/wiki/Q7852668","display_name":"Tumor-infiltrating lymphocytes","level":4,"score":0.35910001397132874},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.33660000562667847},{"id":"https://openalex.org/C2781053074","wikidata":"https://www.wikidata.org/wiki/Q21100639","display_name":"PD-L1","level":4,"score":0.2906999886035919},{"id":"https://openalex.org/C2908812692","wikidata":"https://www.wikidata.org/wiki/Q3269477","display_name":"Lymphocytic infiltration","level":2,"score":0.2849000096321106},{"id":"https://openalex.org/C34626388","wikidata":"https://www.wikidata.org/wiki/Q721129","display_name":"Nomogram","level":2,"score":0.28119999170303345},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.2777000069618225},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.2639999985694885},{"id":"https://openalex.org/C3019096185","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Complete response","level":3,"score":0.26170000433921814},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.2583000063896179},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.25760000944137573},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.25690001249313354},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.2526000142097473}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.64898/2026.10.22.760891","doi":"https://doi.org/10.64898/2026.10.22.760891","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.10.22.760891","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2026/10/23/2026.10.22.760891.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.64898/2026.10.22.760891","doi":"https://doi.org/10.64898/2026.10.22.760891","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.10.22.760891","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2026/10/23/2026.10.22.760891.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[{"id":"https://openalex.org/G2316486796","display_name":null,"funder_award_id":"CEX2020-001024-S/AEI/10.13039/501100011033","funder_id":"https://openalex.org/F4320310210","funder_display_name":"Fundaci\u00f3n Cellex"},{"id":"https://openalex.org/G4731613563","display_name":null,"funder_award_id":"AEI/10.13039/501100011033","funder_id":"https://openalex.org/F4320310210","funder_display_name":"Fundaci\u00f3n Cellex"}],"funders":[{"id":"https://openalex.org/F4320310210","display_name":"Fundaci\u00f3n Cellex","ror":"https://ror.org/019dmpq73"},{"id":"https://openalex.org/F4320330256","display_name":"Fundaci\u00f3n Bancaria Caixa d'Estalvis i Pensions de Barcelona","ror":"https://ror.org/05r3yzw86"},{"id":"https://openalex.org/F4320335598","display_name":"Agencia Estatal de Investigaci\u00f3n","ror":"https://ror.org/003x0zc53"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7223330581.pdf","grobid_xml":"https://content.openalex.org/works/W7223330581.grobid-xml"},"referenced_works_count":3,"referenced_works":["https://openalex.org/W2295598076","https://openalex.org/W6968213571","https://openalex.org/W7168906087"],"related_works":["https://openalex.org/W3196616975","https://openalex.org/W4399662556","https://openalex.org/W3182868971","https://openalex.org/W4379336779","https://openalex.org/W4281776806","https://openalex.org/W4394740779","https://openalex.org/W3091570384","https://openalex.org/W3032241845","https://openalex.org/W4387060891","https://openalex.org/W4393072886"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"Whole-genome":[2],"sequencing":[3],"(WGS)":[4],"enables":[5],"comprehensive":[6],"assessment":[7],"of":[8,28,52,84,123,148,159,334,355],"genomic":[9,365],"biomarkers":[10,347,357],"for":[11,66,369],"precision":[12,370],"oncology":[13],"within":[14],"a":[15,50,81,145,286,290,331],"single":[16],"assay.":[17],"Recent":[18],"studies":[19],"have":[20],"shown":[21],"that":[22,56],"WGS":[23,48,361],"can":[24],"also":[25],"reveal":[26],"features":[27],"the":[29,77,108,121,225,353],"tumor":[30,53,85,299,335],"immune":[31,70,118,164,356,367],"microenvironment,":[32],"including":[33],"T-":[34],"and":[35,63,113,182,223,260,312,317,362,366],"B-cell":[36],"infiltration":[37,55,87,217,337],"1":[38,143],".":[39],"Here,":[40],"we":[41,138],"evaluated":[42,154,191],"whether":[43],"T-cell":[44,54,79,86,92,117,208,216,236,328,336],"receptor":[45,93],"reconstruction":[46],"from":[47,107,202,339,359],"provides":[49,330],"measure":[51,83,333],"is":[57],"orthogonal":[58,226],"to":[59,69,199],"RNA":[60,128],"expression":[61],"profiling":[62,368],"clinically":[64],"informative":[65],"predicting":[67],"response":[68,243,311],"checkpoint":[71,165],"inhibitors":[72,166],"(ICIs).":[73],"Methods":[74],"We":[75],"derived":[76,338],"CIDER":[78,132,207,235,327],"score,":[80],"WGS-based":[82,146],"based":[88],"on":[89],"unique":[90],"reconstructed":[91,340],"complementarity-determining":[94],"region":[95],"3":[96],"(CDR3)":[97],"sequences.":[98,342],"The":[99,206,293,326],"score":[100,209,294,329],"was":[101,153],"characterized":[102],"across":[103,167],"8,275":[104],"metastatic":[105],"tumors":[106],"Hartwig":[109],"Medical":[110],"Foundation":[111],"cohort":[112,158],"validated":[114],"against":[115,133],"RNA-derived":[116],"signatures":[119],"in":[120,155,192,246,250,280],"subset":[122],"3,572":[124],"patients":[125,161,194,281],"with":[126,141,163,174,186,197,213,224,240,298,310,323,344],"matched":[127],"sequencing.":[129],"To":[130],"benchmark":[131],"an":[134,156,214],"independent":[135,157],"DNA-based":[136,227,332],"approach,":[137],"compared":[139],"it":[140,351],"ImmuneLENS":[142,228],",":[144],"metric":[147,229],"lymphocyte":[149],"infiltration.":[150],"Clinical":[151],"utility":[152],"647":[160],"treated":[162,196],"six":[168],"cancer":[169],"types":[170],"by":[171],"assessing":[172],"associations":[173,275],"treatment":[175],"response,":[176],"durable":[177],"clinical":[178,187],"benefit,":[179],"overall":[180,261],"survival,":[181],"progression-free":[183],"survival.":[184],"Associations":[185],"outcomes":[188],"were":[189,238,276],"additionally":[190],"2,432":[193],"not":[195,282],"ICIs":[198],"distinguish":[200],"predictive":[201,287],"prognostic":[203,291],"effects.":[204],"Results":[205],"showed":[210,295],"strong":[211],"concordance":[212],"RNA-based":[215],"signature":[218],"(Pearson\u2019s":[219],"r":[220,231,304],"=":[221,232,253,264,305],"0.80)":[222],"(":[230,303],"0.92).":[233],"Higher":[234],"scores":[237],"associated":[239,309],"improved":[241,318],"ICI":[242],"(median":[244],"20":[245],"responders":[247],"versus":[248],"11":[249,258],"non-responders,":[251],"P":[252,266],"5.7":[254],"\u00d7":[255,269],"10":[256,270],"-":[257,271],")":[259],"survival":[262,313],"(HR":[263],"0.56,":[265],"<":[267],"4.3":[268],"8":[272],").":[273],"These":[274],"attenuated":[277],"or":[278],"absent":[279],"receiving":[283],"ICIs,":[284],"supporting":[285],"rather":[288],"than":[289],"association.":[292],"minimal":[296],"correlation":[297],"mutational":[300],"burden":[301],"(TMB)":[302],"0.035),":[306],"remained":[307],"independently":[308],"after":[314],"covariate":[315],"adjustment,":[316],"patient":[319],"stratification":[320],"when":[321],"combined":[322],"TMB.":[324],"Conclusions":[325],"CDR3":[341],"Together":[343],"established":[345],"WGS-derived":[346],"such":[348],"as":[349],"TMB,":[350],"expands":[352],"repertoire":[354],"obtainable":[358],"routine":[360],"supports":[363],"integrated":[364],"immuno-oncology.":[371]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-10-24T00:00:00"}